Enflonsia in Jordan
How patients in Jordan access Enflonsia (fentanyl transdermal class) via Named Patient Program.
Enflonsia - overview
Enflonsia (fentanyl transdermal class) is manufactured by TBD – verify and indicated for Chronic pain — OUT OF SCOPE (fentanyl class / Schedule II; PlatformCo does not handle controlled substances. Product-name mapping also uncertain — verify FDA label before any future consideration by Fatima's entity.). It is a unverified approved by the US FDA in unverified and may be accessible to patients in Jordan through a Named Patient Program or personal-import pathway.
Access in Jordan
Jordan's JFDA operates a compassionate-use framework for unregistered drugs; requires physician and JFDA approval.
How Reserve Meds coordinates access in Jordan
- Patient or treating physician submits a request.
- We verify clinical appropriateness and Jordan-specific eligibility.
- Treating physician in Jordan issues prescription and clinical justification.
- Country-specific NPP/personal-import forms are prepared and filed.
- We source Enflonsia from a DSCSA-compliant US specialty wholesaler.
- Cold-chain shipment to the patient's physician or hospital pharmacy in Jordan.
Typical timeline for Jordan
End-to-end, most requests are completed in 2-6 weeks. Jordan's tier 2 regulatory maturity typically supports moderate processing times.
What patients and physicians in Jordan ask
- Is the pathway legal in Jordan? Yes - it operates under Jordan's established NPP or personal-import framework.
- Does my insurance cover it? Typically no for NPP drugs; patient prepayment is standard.
- What physician credentials do I need? A licensed physician in Jordan able to issue the prescription and clinical justification.
- What if the drug is in shortage? We will inform you upfront and decline rather than promise what we cannot deliver.
- Can I re-supply? Yes - for chronic therapies we arrange ongoing re-supply.